I might remind investors that there is no other clinically approved treatment for Rett.
As previous releases leading to the FDA approval, adverse reactions weren't unexpected and doesn't go into each child's medical history and what else might be impacting their health.Personally, I'll stick with the FDA review process and their post-market safety monitoring updates before losing too much sleep.
if challenged to write up an opposing report, I'm sure the outlook would still lean to the clinical assessment by the FDA / trial data to date.
- Forums
- ASX - By Stock
- Ann: Pause in Trading
I might remind investors that there is no other clinically...
-
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$21.27 |
Change
0.650(3.15%) |
Mkt cap ! $2.718B |
Open | High | Low | Value | Volume |
$20.84 | $21.56 | $20.76 | $7.760M | 364.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 1378 | $21.24 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$21.29 | 218 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 200 | 21.240 |
3 | 2798 | 21.230 |
2 | 1055 | 21.210 |
2 | 9379 | 21.200 |
1 | 1805 | 21.180 |
Price($) | Vol. | No. |
---|---|---|
21.300 | 12763 | 1 |
21.350 | 30 | 1 |
21.380 | 471 | 1 |
21.400 | 700 | 1 |
21.410 | 25 | 1 |
Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online